TIMP1 and breast carcinoma: Moreover, by analyzing the proteome and phosphoproteome differences of MCF-7 breast cancer cells expressing high or low levels of TIMP-1, the upregulation and hyperphosphorylation of proteins that are directly or indirectly associated with drug resistance were detected in TIMP-1 high-expressing cells [78].